Literature DB >> 17729358

T2-weighted cardiovascular magnetic resonance imaging.

Hassan Abdel-Aty1, Orlando Simonetti, Matthias G Friedrich.   

Abstract

Technical advances in T2-weighted cardiovascular MR (CMR) imaging allow for accurate identification and quantification of tissue injuries that alter myocardial T2 relaxation. Of these, myocardial edema is of special relevance. Increased myocardial water content is an important feature of ischemic as well as nonischemic cardiomyopathies, which are often associated with acute myocardial inflammation. In this article, we review technical considerations and discuss clinical indications of myocardial T2-weighted imaging. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17729358     DOI: 10.1002/jmri.21028

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  76 in total

Review 1.  Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease.

Authors:  M Francone; I Carbone; L Agati; C Bucciarelli Ducci; M Mangia; I Iacucci; C Catalano; R Passariello
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

2.  Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction.

Authors:  Steffen Desch; Hubertus Engelhardt; Josefine Meissner; Ingo Eitel; Mahdi Sareban; Georg Fuernau; Suzanne de Waha; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Int J Cardiovasc Imaging       Date:  2011-01-30       Impact factor: 2.357

3.  Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma.

Authors:  P Thavendiranathan; D Verhaert; K L Kendra; S V Raman
Journal:  Br J Radiol       Date:  2011-05       Impact factor: 3.039

Review 4.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

5.  Novel application of black-blood echo-planar imaging to the assessment of myocardial infarction.

Authors:  Satoshi Okayama; Shiro Uemura; Makoto Watanabe; Yoshinobu Morikawa; Kenji Onoue; Tsunenari Soeda; Hajime Iwama; Satoshi Somekawa; Yukiji Takeda; Hiroki Uramoto; Yoshiyuki Kobayashi; Yoshihiko Saito
Journal:  Heart Vessels       Date:  2010-03-26       Impact factor: 2.037

Review 6.  Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis.

Authors:  Hiroshi Satoh; Makoto Sano; Kenichiro Suwa; Takeji Saitoh; Mamoru Nobuhara; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  World J Cardiol       Date:  2014-07-26

7.  Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling.

Authors:  Adam N Mather; Timothy A Fairbairn; Nigel J Artis; John P Greenwood; Sven Plein
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

Review 8.  Cardiovascular magnetic resonance in heart failure.

Authors:  Theodoros D Karamitsos; Stefan Neubauer
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

9.  Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study.

Authors:  Valentina O Puntmann; Peter C Taylor; Andrew Barr; Bernhard Schnackenburg; Cosima Jahnke; Ingo Paetsch
Journal:  Rheumatology (Oxford)       Date:  2009-12-21       Impact factor: 7.580

Review 10.  Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review.

Authors:  Craig R Butler; Richard Thompson; Mark Haykowsky; Mustafa Toma; Ian Paterson
Journal:  J Cardiovasc Magn Reson       Date:  2009-03-12       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.